Interventional Radiology Market by Product, Procedure, Application and Region – Global Market Size Estimation, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2034
Overview
The Interventional Radiology Market size was valued at USD 32.44 Bn. in 2026, and the total Interventional Radiology revenue is expected to grow at a CAGR of 7.25% from 2026 to 2034, reaching nearly USD 60.91 Bn. by 2034.
Interventional Radiology Market Overview
This report provides a comprehensive and easy-to-follow overview of the Interventional Radiology Market, explaining the concept of interventional radiology, its key users, areas of growth, and its overall importance in modern healthcare. Interventional radiology (IR) is a minimally invasive medical technique that relies on imaging technologies such as X-ray, CT, and ultrasound to guide procedures. This approach enables smaller incisions, reduced risk to patients, and, perhaps most importantly, quicker recovery times. Common interventional radiology procedures include angioplasty and stenting to open blocked arteries, ablation to destroy cancer cells, and embolization to control internal bleeding.
The Interventional Radiology Market is segmented based on the key products used in these procedures. These include catheters, stents, guidewires, and balloon devices, which are critical tools for ensuring successful outcomes in various minimally invasive treatments. The demand for these products continues to grow as hospitals and clinics prioritize efficient and safer treatment options for patients suffering from chronic conditions.
Globally, the Interventional Radiology Market demonstrates regional disparities in access to IR technologies. North America led the market in 2025, attributed to the presence of advanced healthcare infrastructure, high-end hospitals, and early adoption of cutting-edge technologies. The global rise in chronic diseases such as cardiovascular disorders and cancer is significantly increasing the demand for interventional radiology procedures. Both patients and healthcare providers are showing a preference for IR due to its lower risk, minimal hospital stays, and faster recovery compared to traditional surgical methods.
Key players driving innovation in the Interventional Radiology Market include leading medical technology companies such as GE Healthcare, Philips, Siemens Healthineers, and Boston Scientific. These companies are heavily investing in the development of smarter, more precise, and user-friendly IR tools to improve procedural accuracy and patient outcomes. Their continued R&D efforts are helping to shape the future of interventional radiology by integrating advanced imaging, AI-driven diagnostics, and improved device design.
Interventional Radiology Market Growth Outlook
To know about the Research Methodology:-Request Free Sample Report
Interventional Radiology Market Dynamics
Technological Advancements and Innovation in Industry with Rising Prevalence of Chronic Diseases to Drive Interventional Radiology Market Growth
The continuous evolution of imaging and interventional technologies is a primary driver for the Interventional Radiology market growth. Ongoing advancements result in the introduction of newer, more sophisticated equipment and techniques, contributing to market penetration. These innovations often lead to improved patient outcomes, reduced procedural times, and increased overall efficiency, fostering the growth of the IR market.
The escalating incidence of chronic diseases, including cardiovascular diseases, cancer, and neurovascular disorders, is a significant driver for the increased demand for interventional radiology procedures. As these conditions become more prevalent, there is a growing need for advanced diagnostic and therapeutic interventions, presenting a substantial market opportunity for IR. The hallmark of interventional radiology is its minimally invasive nature, contributing to quicker patient recovery times, shorter hospital stays, and lower healthcare costs compared to traditional surgical methods.
This characteristic promotes the adoption of interventional radiology procedures, leading to an increased market share within the medical intervention landscape. The global aging population plays a pivotal role in driving the demand for interventional radiology. With an increasing number of elderly individuals, there is a higher prevalence of diseases that are effectively treated or diagnosed through interventional radiology, such as vascular diseases and cancer. This demographic trend contributes significantly to the overall growth potential of the Interventional Radiology Market.
The growing awareness about the benefits of interventional radiology procedures among healthcare providers and patients alike is a driver for market expansion. As understanding of the efficacy and advantages of these techniques increases, there is a corresponding rise in acceptance, positioning interventional radiology as a viable and preferred option for various medical interventions, aligning with emerging trends in the healthcare industry.
High Cost of Equipment and Procedures and Pricing Analysis to Restraint the Interventional Radiology Market
Acquiring advanced interventional radiology equipment involves substantial initial costs. Additionally, procedural costs are relatively high, limiting accessibility, particularly in developing regions where financial constraints pose Interventional Radiology Market challenges. The economic barriers impede the widespread adoption of interventional radiology technologies and procedures, prompting a need for pricing analysis to enhance affordability.
Reimbursement challenges and uncertainties regarding compensation for interventional radiology procedures pose a significant restraint on market growth. Payers do not consistently cover the full costs of certain procedures, impacting the financial viability for healthcare providers and potentially leading to Interventional Radiology Market fluctuations in terms of procedure volumes and revenue.
The performance of interventional radiology procedures requires specialized skills. The shortage of trained and experienced interventional radiologists is a notable restraint, as it limits the widespread adoption of these techniques. Addressing this workforce gap requires industry education and training initiatives to ensure a skilled workforce and sustained growth of the IR market. Stringent regulations and approval processes for new interventional radiology technologies and procedures present a hurdle to their timely introduction to the Interventional Radiology Market.
Compliance with regulatory requirements is time-consuming and resource-intensive, slowing down innovation and impacting market share for companies in the industry. Some conditions treated through interventional radiology have alternative treatment options. Physicians choose alternative approaches based on patient characteristics, preferences, or the availability of resources, limiting the market penetration of interventional radiology in certain cases. Overcoming this restraint requires demonstrating the unique benefits and efficacy of interventional radiology in comparison to alternatives.
Interventional Radiology Market Segment Analysis:
Based on products, the Interventional Radiology Market is segmented into MRI systems, ultrasound imaging systems, CT scanners, angiography systems, fluoroscopy systems, biopsy devices, and other devices. Among these, CT scanners dominated the Interventional Radiology Market in 2025, primarily due to their high-resolution imaging, rapid scan times, and ability to provide real-time guidance during complex interventional procedures.
They are widely used in procedures such as tumor ablation, angioplasty, and biopsies, where precision is critical. Additionally, advancements in multi-slice CT technology and widespread availability in healthcare facilities have further boosted their adoption. CT scanners are especially preferred for their efficiency in emergency settings and their capability to detect and monitor a broad range of diseases, including cancer and cardiovascular conditions, making them the leading segment in the interventional radiology market.
Based on Procedures, the interventional radiology market is segmented into angiography, angioplasty, biopsy devices, embolization, thrombolysis, vertebroplasty, nephrostomy, and other procedures. Among these, angioplasty dominated the Interventional Radiology Market in 2025. This dominance is largely driven by the increasing incidence of cardiovascular diseases, particularly coronary artery disease, which necessitates minimally invasive techniques to improve blood flow.
Angioplasty, which involves the use of a balloon catheter, often with stent placement, to open narrowed or blocked arteries, is highly favored due to its effectiveness, shorter recovery time, and reduced hospital stay compared to conventional surgeries. The shift towards outpatient treatment models and the rising aging population also contribute significantly to the high adoption of angioplasty within the interventional radiology landscape.
Interventional Radiology Market Regional Insights:
The Interventional Radiology (IR) market in North America represents a leading and mature segment of the global landscape, marked by advanced technology adoption, increasing procedural volumes, and continuous innovation. The region benefits from a well-established healthcare infrastructure, high healthcare expenditure, and a growing preference for minimally invasive procedures. These factors collectively drive substantial market demand across diagnostic and therapeutic interventional radiology applications.
One of the key growth drivers in North America is the rising incidence of chronic diseases such as cancer, cardiovascular disorders, and peripheral artery diseases, which require frequent image-guided procedures. For instance, interventional oncology treatments like radioembolization and tumor ablation are gaining popularity due to reduced recovery times and improved patient outcomes. Similarly, angioplasty and embolization procedures are seeing higher adoption across hospitals and outpatient centers.
Major players such as GE Healthcare, Boston Scientific, and Siemens Healthineers are heavily investing in North America, launching advanced imaging systems and catheter-based tools. For example, Boston Scientific’s Eluvia Drug-Eluting Vascular Stent System and GE’s Discovery IGS 7 interventional X-ray system are widely used in cardiovascular and oncology-focused radiology suites.
Additionally, the region’s regulatory support and reimbursement environment play a crucial role. Favorable insurance coverage for procedures like vertebroplasty and thrombolysis boosts hospital adoption. Investment in AI-integrated imaging platforms and robotic-assisted IR tools further strengthens the market outlook.
In conclusion, North America remains a technologically advanced and innovation-driven hub for interventional radiology, supported by leading manufacturers, growing clinical demand, and an ecosystem focused on patient-centric, minimally invasive care.
Interventional Radiology Market Competitive Landscape
The competitive environment of the North American Interventional Radiology (IR) market is dominated by global medical technology companies, with GE HealthCare and Siemens Healthineers leading the way. These companies offer the most extensive interventional platforms supported by R&D capability, advanced imaging capability, and strategic relationships with product developers, suppliers, and others in the interventional space.
GE HealthCare has considerable strength in the U.S. market through a wide and established hospital network and by leveraging integrated systems with advanced AI capabilities like Discovery and Innova IGS. GE HealthCare aims to sharpen its focus on enhancing precision health through its Edison platform, which utilizes real-time data and imaging automation between humans and machines. Since spinning off from GE in 2024, GE HealthCare has intentionally streamlined and enhanced its interventional solutions addressable market, with a unique focus on cardiovascular and oncology.
Siemens Healthineers is based in Germany but has a robust and influential presence in North America. Both its Artis icono and Nexaris Angio-CT systems are widely used for their hybrid functionality and multi-modality imaging. Siemens employs integrated robotics and image-guided technology in its syngo.via digital ecosystem. Siemens makes substantial investments in innovative solutions and expands its public health impact through global initiatives like UNICEF collaborations.
GE HealthCare has the advantage of leading domestic adoption and an advanced, adaptive workflow; Siemens generally competes on the merits of its aspects of precision and hybrid imaging solutions, while the company's technology platform generally provides comprehensive functionality.
International Radiology Market Recent Developments
• May 2025, USA, United Imaging – Received FDA 510(k) clearance for the uAngio AVIVA interventional X-ray system, introducing intelligent voice-assist and robotic movement features for enhanced workflow efficiency.
• January 2025, USA, NextBioMedical – Gained FDA Investigational New Drug (IND) approval to initiate clinical trials for Nexsphere-F, a genicular artery embolization (GAE) device designed to treat knee osteoarthritis.
• June 2024, USA (Minnesota), GE HealthCare & MediView XR – Launched the first U.S. installation of OmnifyXR, an augmented reality interventional suite combining AR visualization with GE’s imaging systems at North Star Vascular & Interventional.
• April 2024, Germany, Siemens Healthineers – Partnered with Unicef to support diagnostic infrastructure in sub-Saharan Africa through interventional imaging and point-of-care systems, funded by a USD 5 million global health grant.
Interventional Radiology Market Recent Development
| Date | Company | Development | Impact |
|---|---|---|---|
| 12 February 2025 | Siemens Healthineers | Launched the ARTIS icono biplane system featuring enhanced AI-driven imaging for complex neurovascular interventions. | Significantly improves procedural precision and reduces radiation exposure for both patients and clinicians. |
| 18 March 2025 | Boston Scientific | Received FDA clearance for the next-generation Vici Venous Stent System designed for deep venous obstructions. | Enhances stent durability and clinical outcomes for patients suffering from venous insufficiency. |
| 05 May 2025 | GE HealthCare | Unveiled the Allia IGS 7 platform with expanded robotic-assisted capabilities for interventional oncology. | Streamlines workflow efficiency and enables more accurate tumor targeting during ablation procedures. |
| 22 July 2025 | Philips | Announced a strategic partnership with Image-Guided Therapy centers to integrate cloud-based diagnostics into radiology suites. | Facilitates real-time data sharing, improving decision-making speed in minimally invasive treatments. |
Interventional Radiology Market Scope: Inquire before buying
| Interventional Radiology Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | USD 32.44 Bn. |
| Forecast Period 2026 to 2034 CAGR: | 7.25% | Market Size in 2034: | USD 60.91 Bn. |
| Segments Covered: | by Product | MRI systems ultrasound imaging systems CT scanners, angiography systems fluoroscopy systems biopsy devices Other devices |
|
| by Procedure | Angiography Angioplasty Biopsy devices Embolization Thrombolysis Vertebroplasty Nephrostomy Other procedures |
||
| by Application | Cardiology Urology & nephrology Oncology Gastroenterology Other applications |
||
Intervational Radiology Market by Region
North America (United States, Canada, and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, and the Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, ASEAN, and the Rest of APAC)
Middle East & Africa (South Africa, GCC, Nigeria, Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Intervational Radiology Market Key Players
North America
1. GE HealthCare – USA
2. Boston Scientific Corporation – USA
3. Abbott Laboratories – USA
4. AngioDynamics, Inc. – USA
5. Merit Medical Systems, Inc. – USA
Europe
1. Siemens Healthineers – Germany
2. Philips Healthcare – Netherlands
3. Becton, Dickinson and Company (BD) – UK operations (global HQ in USA)
4. Terumo Europe N.V. – Belgium
5. Canon Medical Systems Europe – Netherlands
Asia-Pacific
1. Shimadzu Corporation – Japan
2. Fujifilm Holdings Corporation – Japan
3. Samsung Medison (subsidiary of Samsung Electronics) – South Korea
4. MicroPort Scientific Corporation – China
5. Trivitron Healthcare – India
Frequently Asked Questions:
1. What is the Interventional Radiology Market?
Ans: The Interventional Radiology Market refers to the specialized sector within medical imaging that focuses on minimally invasive procedures guided by real-time imaging technologies.
2. What are the Key Driving Factors for Interventional Radiology Market Growth?
Ans: Key growth drivers include the rising prevalence of chronic diseases, technological advancements in imaging, and the shift towards less invasive medical interventions.
3. Which Procedures Are Included in Interventional Radiology?
Ans: Interventional Radiology procedures encompass a wide range, including angiography, angioplasty, biopsies, embolization, and other minimally invasive interventions.
4. Who Are the Major Players in the Interventional Radiology Market?
Ans: Major players in the Interventional Radiology Market include Siemens Healthineers, Hitachi, Terumo, Philips, and other prominent manufacturers..
5. How is the Interventional Radiology Market Adapting to Global Healthcare Trends?
Ans: The Interventional Radiology Market is adapting to global healthcare trends by aligning with the preference for minimally invasive interventions, rapid technological adoption, and increased awareness among healthcare professionals.